Atlas Trials

Switching From Oral Dopamine Agonists to Rotigotine

Clinical trial NCT01976871 · COMPLETED

Trial details

NCT number
NCT01976871
Sponsor
John Winkelman, MD, PhD
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Restless Legs SyndromeEkbom SyndromeWillis-Ekbom Disease
Start date
2014-08-01
Primary completion
2015-05-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.